Biomarkers based on epidemiological investigations
Biomarkers have been classified based on the epidemiological investigations exposure to disease & biomarkers of disease which are also used in the investigation of the natural history and prognosis of a disease. In addition to the factors between exposure and disease, biomarkers have the potential to identify the earliest events in the natural history, reducing the rate of misclassification of both disease and exposure, leads to increase potential mechanisms related to the disease pathogenesis, accounting for some of the variability and effect modification of risk prediction. These epidemiological investigations are one of the reasons behind biomarkers to improve validity while reducing bias in the measurement of exposures (or risk factors) for neurological disease.
Related Conference of Biomarkers based on epidemiological investigations
Biomarkers based on epidemiological investigations Conference Speakers
Recommended Sessions
- Biomarkers & Next-Generation Sequencing
- Biomarkers based on epidemiological investigations
- Biomarkers for Cancer Diagnosis
- Biomarkers in Drug discovery and development
- Biomarkers of Cardiovascular disorders
- Discovery of new biomarkers/validation/technologies
- Entrepreneur Investments Meet
- Imaging Technologies and Diagnostic tests of Biomarkers
- Biomarkers for Early Diagnosis and Prognosis
- Biomarkers for non-cancerous diseases
- Biomarkers in Diagnosis: Challenges and Approaches
- Biomarkers in Disease Treatment
- Biomarkers in Immune-Oncology
- Biomarkers of Disorders of the Nervous System
- Biomarkers: Validation & Verification
- Clinical and Biomedical Engineering
- Clinical Research & Biomarkers
- Genomic Biomarkers in Clinical Development
Related Journals
Are you interested in
- Advances in Separation Techniques - ANALYTICA ACTA 2024 (France)
- Analytical Chemistry and Methodology - ANALYTICA ACTA 2024 (France)
- Analytical Technique for Clinical Chemistry - ANALYTICA ACTA 2024 (France)
- Analytical Technique for Thermal analysis - ANALYTICA ACTA 2024 (France)
- Bioanalytical Methodology - ANALYTICA ACTA 2024 (France)
- Biochemistry - ANALYTICA ACTA 2024 (France)
- Biomarkers & Next-Generation Sequencing - Biomarkers 2024 (UK)
- Biomarkers based on epidemiological investigations - Biomarkers 2024 (UK)
- Biomarkers for Cancer Diagnosis - Biomarkers 2024 (UK)
- Biomarkers for Early Diagnosis and Prognosis - Biomarkers 2024 (UK)
- Biomarkers for non-cancerous diseases - Biomarkers 2024 (UK)
- Biomarkers in Diagnosis: Challenges and Approaches - Biomarkers 2024 (UK)
- Biomarkers in Disease Treatment - Biomarkers 2024 (UK)
- Biomarkers in Drug discovery and development - Biomarkers 2024 (UK)
- Biomarkers in Immune-Oncology - Biomarkers 2024 (UK)
- Biomarkers of Cardiovascular disorders - Biomarkers 2024 (UK)
- Biomarkers of Disorders of the Nervous System - Biomarkers 2024 (UK)
- Biomarkers: Validation & Verification - Biomarkers 2024 (UK)
- Biopolymers and Biomaterials - ANALYTICA ACTA 2024 (France)
- Chromatography - ANALYTICA ACTA 2024 (France)
- Clinical and Biomedical Engineering - Biomarkers 2024 (UK)
- Clinical Diagnostics Equipment and Kits - ANALYTICA ACTA 2024 (France)
- Clinical Research & Biomarkers - Biomarkers 2024 (UK)
- Discovery of new biomarkers/validation/technologies - Biomarkers 2024 (UK)
- Electrophoresis - ANALYTICA ACTA 2024 (France)
- Entrepreneur Investments Meet - Biomarkers 2024 (UK)
- Environmental Analytical Chemistry - ANALYTICA ACTA 2024 (France)
- Genomic Biomarkers in Clinical Development - Biomarkers 2024 (UK)
- Hyphenated Techniques - ANALYTICA ACTA 2024 (France)
- Imaging Technologies and Diagnostic tests of Biomarkers - Biomarkers 2024 (UK)
- Innovation in Food Analysis & Testing - ANALYTICA ACTA 2024 (France)
- Mass Spectrometry - ANALYTICA ACTA 2024 (France)
- Method development and validation - ANALYTICA ACTA 2024 (France)
- Microscopy - ANALYTICA ACTA 2024 (France)
- New Instrumentation and Equipment - ANALYTICA ACTA 2024 (France)
- Novel Optical Sensors and Biosensors - ANALYTICA ACTA 2024 (France)
- Pharmaceutical Analytics - ANALYTICA ACTA 2024 (France)
- Polymer Science and Material Science - ANALYTICA ACTA 2024 (France)
- Proteomics and its applications - ANALYTICA ACTA 2024 (France)
- Regulatory issues and Biosafety challenges in bioanalysis - ANALYTICA ACTA 2024 (France)
- Regulatory Issues and Biosafety Challenges in Bioanalysis - ANALYTICA ACTA 2024 (France)
- Spectroscopy - ANALYTICA ACTA 2024 (France)